FX CorDiax Haemodiafilters and FX CorDiax High Flux dialysers 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Fresenius Medical Care 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2015-03-09
  • 사례 출판 날짜
    2015-03-09
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: fresenius medical care fx cordiax haemodiafilters and fx cordiax high flux dialysers medical device manufacturer, fresenius medical care, has issued a medical device safety alert concerning fx cordiax haemodiafilters and fx cordiax high flux dialysers [reference numbers: f00001593, f00001594, f00001595, f00001588, f00001589]. the manufacturer has observed an increase in number of cases of hypersensitivity and hypersensitivity-like reactions during haemodialysis and haemodiafiltration treatments. these reactions occurred mainly in the first treatment hour or within the first week of treatment, and are potentially life threatening. the manufacturer is advising users to carefully monitor patients who have not been treated with the affected device or have a history of allergy or asthma. patients with known hypersensitivity to any of the dialyser’s materials must not be treated with the dialysers. if severe hypersensitivity and hypersensitivity-like reactions occur, the dialysis must be discontinued and the blood from the extracorporeal system must not be returned to the patient. the manufacturer has also updated the instructions for use. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 9 march 2015.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Fresenius Medical Care FX CorDiax Haemodiafilters and FX CorDiax High Flux dialysers
  • Manufacturer

Manufacturer